Is EMvision Medical Devices Limited a good investment? EMvision Medical Devices Limited (EMV.AX) is currently trading at 1.57 AUD.
Earnings Schedule: EMvision Medical Devices Limited is expected to release its next earnings report on Sept. 2, 2026. The market consensus estimate for Forward EPS is -0.11.
No, it does not currently pay a dividend.
EMvision Medical Devices Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Sept. 2, 2026. The company currently has a trailing EPS of -0.12.
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Community Discussion